The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
A unifying hypothesis for the cause of amyotrophic lateral sclerosis, parkinsonism, and alzheimer disease
Abstract
The causes of amyotrophic lateral sclerosis, Parkinson disease, and Alzheimer disease are unknown. Furthermore, treatment for two of these conditions is almost totally lacking. The thesis is presented that each of these disorders is due to lack of a disorder‐specific neurotrophic hormone. The hormone would be elaborated or stored in the target of the affected neurons. It would be released by the postsynaptic cell and then exert its effect in a retrograde fashion after being taken up by the presynaptic terminal. In the lower motor neuron syndromes of amyotrophic lateral sclerosis, failure of muscle cells to release the appropriate motor neuron syndromes of amyotrophic lateral sclerosis, failure of muscle cells to release the appropriate motor neurotrophic hormone would result in impaired function of anterior horn cells. In Parkinson disease, the neurotrophic failure would be characterized by inability of striatal cells to provide the required dopamine neurotrophic hormone with resulting impairment of substantia nigra cells. In Alzheimer disease, the abnormalities would lie in failure of the hippocampus and cortical cells to supply the relevant cholinergic neurotrophic hormone with resulting impairment of medial septal and nucleus basalis neurons. Central nervous system tissue culture provides a convenient system in which to assay these neurotrophic hormones and should permit a test of the hypothesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Blessed, G., Tomlinson, B. E., & Roth, M. (1968) · British Journal of Psychiatry · doi:10.1192/bjp.114.512.797 · Cited by 4,117
SELECTIVE LOSS OF CENTRAL CHOLINERGIC NEURONS IN ALZHEIMER'S DISEASE
DAVIES, P. (1976) · The Lancet · doi:10.1016/s0140-6736(76)91936-x · Cited by 3,565
Growth of a rat neuroblastoma cell line in serum-free supplemented medium.
Bottenstein, J. E., & Sato, G. H. (1979) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.76.1.514 · Cited by 2,276
Alzheimer disease: Evidence for selective loss of cholinergic neurons in the nucleus basalis
Whitehouse, P. J., Price, D. L., Clark, A. W., Coyle, J. T., & DeLong, M. R. (1981) · Annals of Neurology · doi:10.1002/ana.410100203 · Cited by 1,736
Asher, R. (1961) · The Lancet · doi:10.1016/s0140-6736(61)91217-x · Cited by 1,290
Fonnum, F. (1969) · Biochemical Journal · doi:10.1042/bj1150465 · Cited by 1,035
Perl, D. P., & Brody, A. R. (1980) · Science · doi:10.1126/science.7367858 · Cited by 993
Davies, P., Katzman, R., & Terry, R. D. (1980) · Nature · doi:10.1038/288279a0 · Cited by 882
Dementia of the Alzheimer Type
Terry, R. D., & Davies, P. (1980) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.03.030180.000453 · Cited by 529
Brown, M. C., Holland, R. L., & Hopkins, W. G. (1981) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.04.030181.000313 · Cited by 525
Cited by
Cell death during development of the nervous system
Oppenheim, R. W. (1991) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.14.030191.002321 · Cited by 3,084
Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease
Corder, E. H., Saunders, A. M., Risch, N. J., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., Rimmler, J. B., Locke, P. A., Conneally, P. M., Schmader, K. E., et al. (1994) · Nature Genetics · doi:10.1038/ng0694-180 · Cited by 1,920
Williams, L. R., Varon, S., Peterson, G. M., Wictorin, K., Fischer, W., Bjorklund, A., & Gage, F. H. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.23.9231 · Cited by 1,055
Fischer, W., Wictorin, K., Björklund, A., Williams, L. R., Varon, S., & Gage, F. H. (1987) · Nature · doi:10.1038/329065a0 · Cited by 1,024
Murer, M. G., Yan, Q., & Raisman-Vozari, R. (2001) · Progress in Neurobiology · doi:10.1016/s0301-0082(00)00014-9 · Cited by 874
GDNF, NGF and BDNF as Therapeutic Options for Neurodegeneration
Allen, S. J., Watson, J. J., Shoemark, D. K., Barua, N. U., & Patel, N. K. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.01.004 · Cited by 820
“In 1981 a hypothesis was presented by Stanley Appel (Appel, 1981) entitled ‘A unifying hypothesis for the cause of amyotrophic lateral sclerosis, parkinsonism, and Alzheimer disease’.”
BackgroundKatzman, R. (1986) · New England Journal of Medicine · doi:10.1056/nejm198604103141506 · Cited by 801
Predicting Regional Neurodegeneration from the Healthy Brain Functional Connectome
Zhou, J., Gennatas, E. D., Kramer, J. H., Miller, B. L., & Seeley, W. W. (2012) · Neuron · doi:10.1016/j.neuron.2012.03.004 · Cited by 706
“…network connectivity disruption undermines inter-nodal trophic factor support, accelerating disease within nodes lacking collateral trophic sources (Appel, 1981; Salehi et al., 2006); and (4) ''shared vulnerability,'' in which networked regions feature a common gene or protein expression signature…”
BackgroundUchida, Y., Takio, K., Titani, K., Ihara, Y., & Tomonaga, M. (1991) · Neuron · doi:10.1016/0896-6273(91)90272-2 · Cited by 699
Limbic Seizures Increase Neuronal Production of Messenger RNA for Nerve Growth Factor
Gall, C. M., & Isackson, P. J. (1989) · Science · doi:10.1126/science.2549634 · Cited by 616
Evidence for apoptotic cell death in Huntington disease and excitotoxic animal models
Portera-Cailliau, C., Hedreen, J., Price, D., & Koliatsos, V. (1995) · The Journal of Neuroscience · doi:10.1523/jneurosci.15-05-03775.1995 · Cited by 607
Brain-derived neurotrophic factor is reduced in Alzheimer's disease
Connor, B., Young, D., Yan, Q., Faull, R. L. M., Synek, B., & Dragunow, M. (1997) · Molecular Brain Research · doi:10.1016/s0169-328x(97)00125-3 · Cited by 581
The role of neuronal growth factors in neurodegenerative disorders of the human brain
Connor, B., & Dragunow, M. (1998) · Brain Research Reviews · doi:10.1016/s0165-0173(98)00004-6 · Cited by 536
Neurotransmitters in the regulation of neuronal cytoarchitecture
Mattson, M. P. (1988) · Brain Research Reviews · doi:10.1016/0165-0173(88)90020-3 · Cited by 520
Reduced BDNF mRNA Expression in the Parkinson's Disease Substantia Nigra
Howells, D. W., Porritt, M. J., Wong, J. Y. F., Batchelor, P. E., Kalnins, R., Hughes, A. J., & Donnan, G. A. (2000) · Experimental Neurology · doi:10.1006/exnr.2000.7483 · Cited by 513
(1994) · Toxicology and Industrial Health · doi:10.1177/074823379401000603 · Cited by 499
Whittemore, S. R., & Seiger, Å. (1987) · Brain Research Reviews · doi:10.1016/0165-0173(87)90008-7 · Cited by 492
Fahnestock, M., Michalski, B., Xu, B., & Coughlin, M. D. (2001) · Molecular and Cellular Neuroscience · doi:10.1006/mcne.2001.1016 · Cited by 490
Excitatory amino acids and Alzheimer's disease
Greenamyre, J. T., & Young, A. B. (1989) · Neurobiology of Aging · doi:10.1016/0197-4580(89)90143-7 · Cited by 484
Metabolism and possible health effects of aluminum.
Ganrot, P. O. (1986) · Environmental Health Perspectives · doi:10.1289/ehp.8665363 · Cited by 483
Oxidative stress: Free radical production in neural degeneration
Götz, M. E., Künig, G., Riederer, P., & Youdim, M. B. H. (1994) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(94)90055-8 · Cited by 482
Mattson, M., Murrain, M., Guthrie, P., & Kater, S. (1989) · The Journal of Neuroscience · doi:10.1523/jneurosci.09-11-03728.1989 · Cited by 480
“A second major hypothesis for age-and disease-associated neurodegeneration postulates that deficiencies in specific growth factors lead to the loss of neurons (Appel, 1986; Fine and Rubin, 1988).”
BackgroundCholine Acetyltransferase Activity in Striatum of Neonatal Rats Increased by Nerve Growth Factor
Mobley, W. C., Rutkowski, J. L., Tennekoon, G. I., Buchanan, K., & Johnston, M. V. (1985) · Science · doi:10.1126/science.2861660 · Cited by 480
Hefti, F., Hartikka, J., & Knusel, B. (1989) · Neurobiology of Aging · doi:10.1016/0197-4580(89)90118-8 · Cited by 466
Hefti, F., Dravid, A., & Hartikka, J. (1984) · Brain Research · doi:10.1016/0006-8993(84)91237-x · Cited by 447
Intracerebral Neural Implants: Neuronal Replacement and Reconstruction of Damaged Circuitries
Björklund, A., & Stenevi, U. (1984) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.07.030184.001431 · Cited by 418
Noradrenergic mechanisms in neurodegenerative diseases: a theory
Marien, M. R., Colpaert, F. C., & Rosenquist, A. C. (2004) · Brain Research Reviews · doi:10.1016/j.brainresrev.2004.02.002 · Cited by 414
Nerve growth factor and Alzheimer's disease
Hefti, F., & Weiner, W. J. (1986) · Annals of Neurology · doi:10.1002/ana.410200302 · Cited by 382
Localization of FGF receptor mRNA in the adult rat central nervous system by in situ hybridization
Wanaka, A., Johnson, E. M., & Milbrand, J. (1990) · Neuron · doi:10.1016/0896-6273(90)90164-b · Cited by 381
Loss of the p53 tumor suppressor gene protects neurons from kainate- induced cell death
Morrison, R., Wenzel, H., Kinoshita, Y., Robbins, C., Donehower, L., & Schwartzkroin, P. (1996) · The Journal of Neuroscience · doi:10.1523/jneurosci.16-04-01337.1996 · Cited by 375
Oppenheim, R. W., Prevette, D., Tytell, M., & Homma, S. (1990) · Developmental Biology · doi:10.1016/0012-1606(90)90180-q · Cited by 331
Sobreviela, T., Clary, D. O., Reichardt, L. F., Brandabur, M. M., Kordower, J. H., & Mufson, E. J. (1994) · Journal of Comparative Neurology · doi:10.1002/cne.903500407 · Cited by 325
Morphological response of axotomized septal neurons to nerve growth factor
Gage, F. H., Armstrong, D. M., Williams, L. R., & Varon, S. (1988) · Journal of Comparative Neurology · doi:10.1002/cne.902690112 · Cited by 321
Ferrari, G., Minozzi, M.-C., Toffano, G., Leon, A., & Skaper, S. D. (1989) · Developmental Biology · doi:10.1016/0012-1606(89)90305-9 · Cited by 313
Mufson, E. J., Kroin, J. S., Sendera, T. J., & Sobreviela, T. (1999) · Progress in Neurobiology · doi:10.1016/s0301-0082(98)00059-8 · Cited by 298
Heimer, L., Harlan, R. E., Alheid, G. F., Garcia, M. M., & de Olmos, J. (1997) · Neuroscience · doi:10.1016/s0306-4522(96)00405-8 · Cited by 288
Survival of Adult Basal Forebrain Cholinergic Neurons After Loss of Target Neurons
Sofroniew, M. V., Galletly, N. P., Isacson, O., & Svendsen, C. N. (1990) · Science · doi:10.1126/science.1688664 · Cited by 284
Tuszynski, M., U, H., Amaral, D., & Gage, F. (1990) · The Journal of Neuroscience · doi:10.1523/jneurosci.10-11-03604.1990 · Cited by 282
Cell loss and shrinkage in the nucleus basalis Meynert complex in Alzheimer's disease
Vogels, O. J. M., Broere, C. A. J., Ter Laak, H. J., Ten Donkelaar, H. J., Nieuwenhuys, R., & Schulte, B. P. M. (1990) · Neurobiology of Aging · doi:10.1016/0197-4580(90)90056-6 · Cited by 279
Scott, S., Mufson, E., Weingartner, J., Skau, K., & Crutcher, K. (1995) · The Journal of Neuroscience · doi:10.1523/jneurosci.15-09-06213.1995 · Cited by 264
Potential occupational risks for neurodegenerative diseases
Park, R. M., Schulte, P. A., Bowman, J. D., Walker, J. T., Bondy, S. C., Yost, M. G., Touchstone, J. A., & Dosemeci, M. (2005) · American Journal of Industrial Medicine · doi:10.1002/ajim.20178 · Cited by 256
Calne, D. B., Mcgeer, E., Eisen, A., & Spencer, P. (1986) · The Lancet · doi:10.1016/s0140-6736(86)90469-1 · Cited by 255
The role of cortical connectivity in Alzheimer's disease pathogenesis: A review and model system
de LaCoste, M.-C., & White, C. L. (1993) · Neurobiology of Aging · doi:10.1016/0197-4580(93)90015-4 · Cited by 253
Reimagining cholinergic therapy for Alzheimer’s disease
Giacobini, E., Cuello, A. C., & Fisher, A. (2022) · Brain · doi:10.1093/brain/awac096 · Cited by 187
Fragmentation of the Golgi apparatus of motor neurons in amyotrophic lateral sclerosis.
(1992) · PubMed Central · Cited by 150
Overlap between neurodegenerative disorders
Armstrong, R. A., Lantos, P. L., & Cairns, N. J. (2005) · Neuropathology · doi:10.1111/j.1440-1789.2005.00605.x · Cited by 146
Traffic at the intersection of neurotrophic factor signaling and neurodegeneration
Salehi, A., Delcroix, J.-D., & Mobley, W. C. (2003) · Trends in Neurosciences · doi:10.1016/s0166-2236(02)00038-3 · Cited by 131
A comparison of familial and sporadic Alzheimer's disease
Duara, R., Lopez-Alberola, R. F., Barker, W. W., Loewenstein, D. A., Zatinsky, M., Eisdorfer, C. E., & Weinberg, G. B. (1993) · Neurology · doi:10.1212/wnl.43.7.1377 · Cited by 122
Imaging plus X: multimodal models of neurodegenerative disease
Oxtoby, N. P., & Alexander, D. C. (2017) · Current Opinion in Neurology · doi:10.1097/wco.0000000000000460 · Cited by 105
Hypothesis: microtubules, a key to Alzheimer disease
Matsuyama, S. S., & Jarvik, L. F. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.20.8152 · Cited by 95
Lucidi‐Phillipi, C. A., Gage, F. H., Shults, C. W., Jones, K. R., Reichardt, L. F., & Kang, U. J. (1995) · Journal of Comparative Neurology · doi:10.1002/cne.903540306 · Cited by 72
Mourelatos, Z., Adler, H., Hirano, A., Donnenfeld, H., Gonatas, J. O., & Gonatas, N. K. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.11.4393 · Cited by 66
Neurotrophin receptor agonists and antagonists as therapeutic agents: An evolving paradigm
Josephy-Hernandez, S., Jmaeff, S., Pirvulescu, I., Aboulkassim, T., & Saragovi, H. U. (2017) · Neurobiology of Disease · doi:10.1016/j.nbd.2016.08.004 · Cited by 54
Epicentral Disruption of Structural Connectivity in Alzheimer's Disease
Mallio, C. A., Schmidt, R., de Reus, M. A., Vernieri, F., Quintiliani, L., Curcio, G., Beomonte Zobel, B., Quattrocchi, C. C., & van den Heuvel, M. P. (2015) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12397 · Cited by 39
Metadata
- Authors
- Appel, S. H.
- Venue
- Annals of Neurology
- Publisher
- Wiley
- Published
- 1981-12
- Volume
- 10
- Issue
- 6
- Pages
- 499-505
- ISSN
- 0364-5134 (ISSN-L)
- 1531-8249
- OpenAlex
- W2005780620
- Cited by
- 698
- References
- 29
- FWCI
- 4.17
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.